Pet Diabetes Management Market
Pet Diabetes Management Market Forecasts to 2034 - Global Analysis By Animal Type (Dogs, Cats), Care Component, Care Setting, Distribution Channel, Monitoring Method, Disease Management Stage, and By Geography
Market Dynamics:
Driver:
Rising diabetes diagnosis and advances in glucose monitoring
Rising diabetes prevalence in dogs and cats, greater veterinary screening, and stronger owner awareness are expanding demand for insulin therapies, glucose monitors, prescription diets and monitoring consumables. Continuous glucose sensors, capillary meters and urine ketone testing are improving at-home glycemic control and earlier detection of complications. Longer companion-animal lifespans and higher per-pet spending support sustained treatment. Clinics and owners increasingly seek convenient, reliable tools that fit daily routines, supporting repeat purchases across diagnosis, stabilization and long-term management.
Restraint:
Lifelong treatment cost and owner adherence challenges
Managing pet diabetes requires lifelong insulin, consistent monitoring, prescription nutrition and regular veterinary review, creating ongoing costs that can discourage owners, particularly in multi-pet or price-sensitive households. Insulin storage, dosing accuracy, sensor replacement and visit frequency add complexity. Owners may struggle to interpret readings or maintain schedules, reducing outcomes and repeat purchase consistency. Uneven access to specialist endocrinology expertise and variable product availability across regions further constrain adoption, while reimbursement remains limited outside insured pet populations.
Opportunity:
Connected monitoring and individualized care pathways
Connected glucose sensors, mobile apps and veterinary portals can link home readings with clinical review, enabling earlier intervention and better adherence. Integrating insulin, diets and consumables into structured care plans supports bundle sales and retention. Practitioner partnerships, online pet pharmacies and teleconsultation extend reach beyond urban clinics. There is scope for size- and species-specific devices, owner education and reminder systems, plus insurer collaboration to improve affordability. Providers combining credible evidence, convenience and coordinated veterinary support can differentiate in a crowded, price-sensitive category.
Threat:
Product reliability, treatment complexity and price competition
Inconsistent sensor accuracy, insulin handling errors and variable veterinary protocols can undermine owner confidence and clinical outcomes. Lower-priced substitutes, unregulated online sellers and inconsistent product claims pressure margins and complicate purchasing decisions. Regulatory variation across markets affects device approval and labeling. Shortages of trained veterinary staff and specialist endocrinology capacity can limit adoption of advanced monitoring. Manufacturers must maintain quality, traceability and clear guidance while demonstrating measurable glycemic benefits to sustain veterinary endorsement and owner trust.
Covid-19 Impact:
The COVID-19 pandemic disrupted veterinary appointments, specialist retail, travel and pet-care supply chains, while shifting more purchasing and advice-seeking online. Some owners postponed non-urgent services, but increased time at home and heightened attention to animal wellbeing supported demand for home-use products and digital support. Providers responded with e-commerce, teleconsultation and flexible scheduling. As restrictions eased, in-person services recovered, but demand for convenience and clear product information remained. The effect varied by market, depending on clinical need, discretionary spending and reliance on in-person experiences where available.
The Dogs segment is expected to be the largest during the forecast period
The Dogs segment is expected to account for a leading share of the pet diabetes management market during the forecast period. Its position reflects the relevance of this group to the addressable companion-animal population and the breadth of use across the market's principal animal type applications. Established product availability, owner familiarity and professional recommendations support demand, while a wide range of care needs encourages repeat purchasing or service use. Market participants are expected to prioritize this segment through targeted product development, broader distribution and clearer use guidance.
The Monitoring Consumables segment is expected to have the highest CAGR during the forecast period
The Monitoring Consumables segment is expected to have the highest CAGR during the forecast period as providers expand targeted solutions and improve access through veterinary, specialist retail and digital channels. Demand is supported by growing awareness of the relevant need, improved product formulation or service delivery, and increased owner willingness to invest in tailored companion-animal care. As evidence, convenience and availability improve, this segment may attract new entrants and encourage established providers to broaden their portfolios.
Region with largest share:
North America is expected to account for a leading share of the pet diabetes management market, supported by high companion-animal ownership, comparatively developed veterinary infrastructure, established pet specialty retail and relatively high per-pet expenditure. The United States represents a major demand center because owners have access to veterinary clinics, online pet-care platforms and a broad selection of specialized products and services. Canada contributes through a mature pet-care ecosystem and established companion-animal health providers. Market adoption is also supported by insurance availability, consumer awareness and product innovation, although adoption differs by income, geography and veterinary access.
Region with highest CAGR:
Asia Pacific is expected to exhibit strong growth in the pet diabetes management market as pet ownership, urban household formation, veterinary service availability and organized pet retail expand across major markets. China, Japan, South Korea, India and Australia offer different adoption pathways, reflecting differences in purchasing power, veterinary infrastructure, product regulation and the role of digital commerce. Growing awareness of preventive care and rising demand for premium companion-animal products are likely to support market development. Expansion will depend on localized products, professional education and compliance with national animal-health and consumer-protection requirements.
Key players in the market
Some of the key players in the Global Pet Diabetes Management Market include Zoetis Inc., Boehringer Ingelheim Animal Health, Merck Animal Health, Elanco Animal Health, Dechra Pharmaceuticals PLC, Virbac, Vetoquinol, IDEXX Laboratories, Inc., Antech Diagnostics, Abbott Laboratories, Becton, Dickinson and Company, i-SENS, Inc., PetTest, Covetrus, Inc., Hill's Pet Nutrition, Trividia Health, Inc..
Key Developments:
In September 2026, American Animal Hospital Association released updated canine diabetes-management guidelines covering diagnosis, insulin treatment, continuous glucose monitoring, dietary management and follow-up care.
In May 2026, ALR Technologies SG Ltd. made its GluCurve continuous glucose monitoring system available in Canada for dogs and cats, providing frequent readings through a pet-specific sensor, mobile app and veterinary portal.
In April 2026, American Animal Hospital Association issued updated feline diabetes guidelines addressing SGLT2-inhibitor therapy, insulin protocols and expanded continuous glucose monitoring for cats.
Animal Types Covered:
• Dogs
• Cats
Care Components Covered:
• Insulin and Glucose-Lowering Therapies
• Glucose Monitoring Devices
• Prescription Diets
• Monitoring Consumables
Care Settings Covered:
• Veterinary Hospitals and Clinics
• Specialty Veterinary Endocrinology Practices
• Home-Based Monitoring
Distribution Channels Covered:
• Veterinary Pharmacies
• Retail Pharmacies
• Online Pet Pharmacies
Monitoring Methods Covered:
• Continuous Glucose Monitoring Sensors
• Capillary Blood Glucose Meters
• Urine Glucose and Ketone Testing
Disease Management Stages Covered:
• Initial Diagnosis and Stabilization
• Long-Term Glycemic Management
• Complication and Comorbidity Management
Regions Covered:
• North America
o United States
o Canada
o Mexico
• Europe
o United Kingdom
o Germany
o France
o Italy
o Spain
o Netherlands
o Belgium
o Sweden
o Switzerland
o Poland
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Thailand
o Malaysia
o Singapore
o Vietnam
o Rest of Asia Pacific
• South America
o Brazil
o Argentina
o Colombia
o Chile
o Peru
o Rest of South America
• Rest of the World (RoW)
o Middle East
§ Saudi Arabia
§ United Arab Emirates
§ Qatar
§ Israel
§ Rest of Middle East
o Africa
§ South Africa
§ Egypt
§ Morocco
§ Rest of Africa
What our report offers:
• Market share assessments for regional and country-level segments
• Strategic recommendations for new entrants
• Covers market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032, and 2034
• Market trends, including drivers, constraints, opportunities, threats, challenges, investment opportunities, and recommendations
• Strategic recommendations for key business segments based on market estimations
• Competitive landscape mapping and assessment of key industry trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends and assessment of the latest technological advancements
Free Customization Offerings:
All customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, forecasts, and CAGR of any prominent country as per the client's interest (subject to feasibility assessment)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations
2 Research Framework
2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
2.4.1 Data Collection (Primary and Secondary)
2.4.2 Data Modeling and Estimation Techniques
2.4.3 Data Validation and Triangulation
2.4.4 Analytical and Forecasting Approach
3 Market Dynamics and Trend Analysis
3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook
4 Competitive and Strategic Assessment
4.1 Porter's Five Forces Analysis
4.1.1 Supplier Bargaining Power
4.1.2 Buyer Bargaining Power
4.1.3 Threat of Substitutes
4.1.4 Threat of New Entrants
4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison
5 Global Pet Diabetes Management Market, By Animal Type
5.1 Dogs
5.2 Cats
6 Global Pet Diabetes Management Market, By Care Component
6.1 Insulin and Glucose-Lowering Therapies
6.2 Glucose Monitoring Devices
6.3 Prescription Diets
6.4 Monitoring Consumables
7 Global Pet Diabetes Management Market, By Care Setting
7.1 Veterinary Hospitals and Clinics
7.2 Specialty Veterinary Endocrinology Practices
7.3 Home-Based Monitoring
8 Global Pet Diabetes Management Market, By Distribution Channel
8.1 Veterinary Pharmacies
8.2 Retail Pharmacies
8.3 Online Pet Pharmacies
9 Global Pet Diabetes Management Market, By Monitoring Method
9.1 Continuous Glucose Monitoring Sensors
9.2 Capillary Blood Glucose Meters
9.3 Urine Glucose and Ketone Testing
10 Global Pet Diabetes Management Market, By Disease Management Stage
10.1 Initial Diagnosis and Stabilization
10.2 Long-Term Glycemic Management
10.3 Complication and Comorbidity Management
11 Global Pet Diabetes Management Market, By Geography
11.1 North America
11.1.1 United States
11.1.2 Canada
11.1.3 Mexico
11.2 Europe
11.2.1 United Kingdom
11.2.2 Germany
11.2.3 France
11.2.4 Italy
11.2.5 Spain
11.2.6 Netherlands
11.2.7 Belgium
11.2.8 Sweden
11.2.9 Switzerland
11.2.10 Poland
11.2.11 Rest of Europe
11.3 Asia Pacific
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 South Korea
11.3.5 Australia
11.3.6 Indonesia
11.3.7 Thailand
11.3.8 Malaysia
11.3.9 Singapore
11.3.10 Vietnam
11.3.11 Rest of Asia Pacific
11.4 South America
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Colombia
11.4.4 Chile
11.4.5 Peru
11.4.6 Rest of South America
11.5 Rest of the World (RoW)
11.5.1 Middle East
11.5.1.1 Saudi Arabia
11.5.1.2 United Arab Emirates
11.5.1.3 Qatar
11.5.1.4 Israel
11.5.1.5 Rest of Middle East
11.5.2 Africa
11.5.2.1 South Africa
11.5.2.2 Egypt
11.5.2.3 Morocco
11.5.2.4 Rest of Africa
12 Strategic Market Intelligence
12.1 Industry Value Network and Supply Chain Assessment
12.2 White-Space and Opportunity Mapping
12.3 Product Evolution and Market Life Cycle Analysis
12.4 Channel, Distributor, and Go-to-Market Assessment
13 Industry Developments and Strategic Initiatives
13.1 Mergers and Acquisitions
13.2 Partnerships, Alliances, and Joint Ventures
13.3 New Product Launches and Certifications
13.4 Capacity Expansion and Investments
13.5 Other Strategic Initiatives
14 Company Profiles
14.1 Zoetis Inc.
14.2 Boehringer Ingelheim Animal Health
14.3 Merck Animal Health
14.4 Elanco Animal Health
14.5 Dechra Pharmaceuticals PLC
14.6 Virbac
14.7 Vetoquinol
14.8 IDEXX Laboratories, Inc.
14.9 Antech Diagnostics
14.10 Abbott Laboratories
14.11 Becton, Dickinson and Company
14.12 i-SENS, Inc.
14.13 PetTest
14.14 Covetrus, Inc.
14.15 Hill's Pet Nutrition
14.16 Trividia Health, Inc.
List of Tables
1 Global Pet Diabetes Management Market Outlook, By Region (2023–2034) ($MN)
2 Global Pet Diabetes Management Market Outlook, By Animal Type (2023–2034) ($MN)
3 Global Pet Diabetes Management Market Outlook, By Dogs (2023–2034) ($MN)
4 Global Pet Diabetes Management Market Outlook, By Cats (2023–2034) ($MN)
5 Global Pet Diabetes Management Market Outlook, By Care Component (2023–2034) ($MN)
6 Global Pet Diabetes Management Market Outlook, By Insulin and Glucose-Lowering Therapies (2023–2034) ($MN)
7 Global Pet Diabetes Management Market Outlook, By Glucose Monitoring Devices (2023–2034) ($MN)
8 Global Pet Diabetes Management Market Outlook, By Prescription Diets (2023–2034) ($MN)
9 Global Pet Diabetes Management Market Outlook, By Monitoring Consumables (2023–2034) ($MN)
10 Global Pet Diabetes Management Market Outlook, By Care Setting (2023–2034) ($MN)
11 Global Pet Diabetes Management Market Outlook, By Veterinary Hospitals and Clinics (2023–2034) ($MN)
12 Global Pet Diabetes Management Market Outlook, By Specialty Veterinary Endocrinology Practices (2023–2034) ($MN)
13 Global Pet Diabetes Management Market Outlook, By Home-Based Monitoring (2023–2034) ($MN)
14 Global Pet Diabetes Management Market Outlook, By Distribution Channel (2023–2034) ($MN)
15 Global Pet Diabetes Management Market Outlook, By Veterinary Pharmacies (2023–2034) ($MN)
16 Global Pet Diabetes Management Market Outlook, By Retail Pharmacies (2023–2034) ($MN)
17 Global Pet Diabetes Management Market Outlook, By Online Pet Pharmacies (2023–2034) ($MN)
18 Global Pet Diabetes Management Market Outlook, By Monitoring Method (2023–2034) ($MN)
19 Global Pet Diabetes Management Market Outlook, By Continuous Glucose Monitoring Sensors (2023–2034) ($MN)
20 Global Pet Diabetes Management Market Outlook, By Capillary Blood Glucose Meters (2023–2034) ($MN)
21 Global Pet Diabetes Management Market Outlook, By Urine Glucose and Ketone Testing (2023–2034) ($MN)
22 Global Pet Diabetes Management Market Outlook, By Disease Management Stage (2023–2034) ($MN)
23 Global Pet Diabetes Management Market Outlook, By Initial Diagnosis and Stabilization (2023–2034) ($MN)
24 Global Pet Diabetes Management Market Outlook, By Long-Term Glycemic Management (2023–2034) ($MN)
25 Global Pet Diabetes Management Market Outlook, By Complication and Comorbidity Management (2023–2034) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY

We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.